Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Mallory McFarland

Physician Assistant Live Oak, TX Physician Assistant

NPI 1700550662 CMS profile 11236300

12850 Toepperwein Rd, Live Oak, TX 78233

Open in the dashboard

General payments

$8,131

374 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mallory McFarland of Live Oak, TX is reported in the CMS Open Payments database as having received $8,131 across 374 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,323 97
2024 General $1,845 101
2023 General $1,976 82
2022 General $1,809 84
2021 General $179 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mallory McFarland
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Mallory McFarland were reported at $2,323. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Mallory McFarland Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $179 $132 $37–$438 $132
2022 $1,809 $155 $48–$522 $149
2023 $1,976 $167 $52–$557 $160
2024 $1,845 $178 $55–$600 $164
2025 $2,323 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,656 117 payments
  2. Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,028 82 payments
  3. Janssen Biotech, Inc. $505 21 payments
  4. QOL Medical, LLC $368 12 payments
  5. Madrigal Pharmaceuticals $353 10 payments
  6. Genzyme Corporation $320 11 payments
  7. Lilly USA, LLC $313 13 payments
  8. Phathom Pharmaceuticals, Inc. $295 12 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $266 13 payments
  10. Regeneron Healthcare Solutions, Inc. $261 5 payments
  11. Other $1,764 78 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,049 370 payments
  2. Education $82 4 payments
Products named General payments · program years 2021–2025
  1. SKYRIZI $960 36 payments
  2. RINVOQ $859 33 payments
  3. XIFAXAN $802 63 payments
  4. TREMFYA $349 14 payments
  5. REZDIFFRA $321 8 payments
  6. DUPIXENT Immunology $320 11 payments
  7. OMVOH $313 13 payments
  8. LINZESS $313 15 payments
  9. DUPIXENT Inflammation And Immunology $261 5 payments
  10. IBSRELA $253 7 payments
  11. Other $3,821 205 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

321

Median for Physician Assistant: 241

Drug cost

$8,010

Median for Physician Assistant: $4,110

Branded share of claims

11.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dicyclomine Hcl Generic 56 $1,326
Pantoprazole Sodium Generic 74 $1,143
Cholestyramine Cholestyramine (With Sugar) Brand 13 $974
Sucralfate Generic 37 $952
Omeprazole Generic 49 $951
Colestipol Hcl Generic 12 $918
Famotidine Generic 30 $581
Ondansetron Odt Ondansetron Brand 23 $525
Esomeprazole Magnesium Generic 14 $432
Hydrocortisone Generic 13 $210

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$22,365

Medicare's payments for the services billed

Medicare patients

250

Average age 74

Services billed

335

162 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Diabetes 38%
Ischemic heart disease 38%
Chronic kidney disease 34%
Depression 28%
Osteoporosis 21%
Atrial fibrillation 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 26 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XIFAXAN
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $201
$201 — —
VOQUEZNA
  • Phathom Pharmaceuticals, Inc. $197
$197 — —
OMVOH
  • Lilly USA, LLC $167
$167 — —
SKYRIZI
  • AbbVie, Inc. $165
$165 — —
MAVYRET
  • AbbVie, Inc. $134
$134 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 26 with Patron

Records

374 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record